ℹ️ Compiled from public regulatory records · Last regulator revision: December 16, 2025🚩 Report this page
Adenosine Triphosphate
Active ingredient
Sold as Hydrate 2 · Hydrate 1
US FDA
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 2
- FDA reports (12 mo)
- 1
Overview
Adenosine Triphosphate is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 2 | December 16, 2025 |
USUnited States· FDA
2 products
Uses
**
How to take
Sources & citations
- [1]FDA DailyMed · 1122605f-715e-4f… · revised December 16, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.